Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies

Int J Cardiol. 2024 Apr 1:400:131803. doi: 10.1016/j.ijcard.2024.131803. Epub 2024 Jan 21.

Authors

Luis Ortega-Paz¹, Marc Bonaca², Dominick J Angiolillo³

Affiliations

¹ Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.
² University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.
³ Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA. Electronic address: dominick.angiolillo@jax.ufl.edu.

PMID: 38262483
DOI: 10.1016/j.ijcard.2024.131803

No abstract available

Publication types

Editorial

MeSH terms

Acute Coronary Syndrome* / therapy
Anticholesteremic Agents*
Cholesterol, LDL
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Hypercholesterolemia* / diagnosis
Hypercholesterolemia* / drug therapy

Substances

Cholesterol, LDL
Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors